Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/α-interferon

R. Katherine Alpaugh, Margaret Von Mehren, Irma Palazzo, Michael B. Atkins, Joseph A. Sparano, Lynn Schuchter, Louis M. Weiner, Janice P. Dutcher

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/α-interferon'. Together they form a unique fingerprint.

Medicine & Life Sciences